P

Pharmena SA
WSE:PHR

Watchlist Manager
Pharmena SA
WSE:PHR
Watchlist
Price: 3.43 PLN -0.29%
Market Cap: zł38.2m

Wall Street
Price Targets

PHR Price Targets Summary
Pharmena SA

There are no price targets for PHR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pharmena SA Competitors:
Price Targets
ZEN
Zen Corporation Group PCL
12% Upside

Revenue
Forecast

-24% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
-24% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for Pharmena SA's revenue is -24%. The projected CAGR for the next 8 years is 77%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
47%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
47%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHR's stock price target?
Not Available

PHR doesn't have any price targets made by Wall Street professionals.

What is Pharmena SA's Revenue forecast?
Projected CAGR
77%

For the last 13 years the compound annual growth rate for Pharmena SA's revenue is -24%. The projected CAGR for the next 8 years is 77%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett